Lupin Limited announces the spin-off of its consumer healthcare division, LupinLife Consumer Healthcare Ltd., into a wholly ...

Pharmaceutical major Lupin Limited has announced the strategic spin-off of its consumer healthcare business, LupinLife ...

This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Mumbai: Global pharma major Lupin Limited, has announced the strategic carve-out of its consumer healthcare business, ...

The product is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery.

The move is part of Lupin's broader strategy to create a specialised consumer healthcare entity, particularly aimed at ...

Lupin launches independent consumer healthcare entity to focus on India's self-care market, led by Anil Kaushal.

Auto majors Hyundai and Maruti Suzuki logged a 6% YoY dip in June sales. Lupin gained momentum with US FDA approval for its ...

Loteprednol Etabonate Ophthalmic Gel is bioequivalent to Lotemax SM Ophthalmic Gel of Bausch & Lomb Inc and will be ...

A host of corporate developments—from regulatory actions and major contracts to earnings, acquisitions, and management ...